Legal Representation
Attorney
Robert E. Hough II
USPTO Deadlines
Next Deadline
1759 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-05-07)
Due Date
May 07, 2030
Grace Period Ends
November 07, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
21 eventsDate | Code | Type | Description |
---|---|---|---|
Dec 23, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Dec 23, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Dec 23, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
May 7, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
May 7, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Mar 4, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Feb 20, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jan 31, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jan 31, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Jan 12, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jan 12, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Jan 12, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Jan 12, 2024 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
Jan 12, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Jan 11, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Jan 11, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Jan 11, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Jan 11, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Jan 8, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
May 8, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Apr 17, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Dietary supplements for pets
First Use Anywhere:
Jun 5, 2021
First Use in Commerce:
Jun 5, 2021
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RX"
USPTO Documents
Loading USPTO documents...